Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Indian J Pharmacol ; 48(4): 382-387, 2016.
Article in English | MEDLINE | ID: mdl-27756948

ABSTRACT

OBJECTIVE: The objective of this study was to evaluate the nephroprotective potential of resveratrol and piperine at same dose on cationic bovine serum albumin (cBSA) induced immune complex glomerulonephritis (ICGN) in BALB/c mice. MATERIALS AND METHODS: Female BALB/c mice were divided into five groups. Group I served as normal control (complete Freund's adjuvant + Saline). Two weeks later, Groups II, III, IV, and V were administered cBSA (13 mg/kg) via the caudal vein 3 times/week every alternative day for 6 weeks to induce ICGN. Simultaneously, from the 3rd week, Groups III, IV were treated with resveratrol and piperine up to 6 weeks. Group V was treated with methylprednisolone considered as a reference standard. RESULTS: There was a significant decrease in albuminuria, serum creatinine, and blood urea nitrogen in Group IV animals when compared with Group III. In addition, Group III and IV have comparable results with cBSA treated animals. Concurrently, same groups showed significantly comparable variance in antioxidant enzymes, phagocytic index, and neutrophil adhesion assay. Group IV found to be more significant in IgG1 reduction than Group III. CONCLUSION: The findings of this study well-demonstrated that piperine has potential immunomodulatory and anti-inflammatory activity than resveratrol; therefore, piperine needs special attention in autoimmunity and inflammation research.


Subject(s)
Alkaloids/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Benzodioxoles/therapeutic use , Glomerulonephritis/drug therapy , Kidney/drug effects , Piperidines/therapeutic use , Polyunsaturated Alkamides/therapeutic use , Stilbenes/therapeutic use , Alkaloids/administration & dosage , Animals , Anti-Inflammatory Agents/administration & dosage , Antioxidants/metabolism , Benzodioxoles/administration & dosage , Catalase/metabolism , Disease Models, Animal , Female , Glomerulonephritis/blood , Glomerulonephritis/immunology , Glomerulonephritis/urine , Glutathione/metabolism , Immunoglobulin G/blood , Kidney/enzymology , Kidney Function Tests , Mice, Inbred BALB C , Piperidines/administration & dosage , Polyunsaturated Alkamides/administration & dosage , Resveratrol , Serum Albumin, Bovine , Stilbenes/administration & dosage , Superoxide Dismutase/metabolism
2.
Pharm Biol ; 53(5): 630-6, 2015 May.
Article in English | MEDLINE | ID: mdl-25472801

ABSTRACT

CONTEXT: Vanillic acid (VA), a flavoring agent used in food and drug products, obtained naturally from the plant Angelica sinensis (Oliv.) Diels (Apiaceae), used in the traditional Chinese medicine. It is reported to possess strong antioxidant, anti-inflammatory, and neuroprotective effects. However, the pharmacological effects on oxidative stress-induced neurodegeneration are not well investigated. OBJECTIVE: This study investigates the neuroprotective effect of VA on streptozotocin (STZ)-induced neurodegeneration in mice through behavioral and biochemical parameters. MATERIALS AND METHODS: The behavioral effects were determined using the Y-maze and open-field habituation memory. In biochemical parameters, acetylcholinesterase (AChE), corticosterone, tumor necrosis factor (TNF)-α, and antioxidants (superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase) were measured. Five groups of animals used were of control, negative control, and three separate groups treated with 25, 50, and 100 mg/kg of VA, respectively, for 28 d. Intracerebroventricular (ICV) injections of STZ were performed for all groups except control on 14th and 16th of 28 d of VA treatment. RESULTS: VA improved spatial learning and memory retention by preventing oxidative stress compared with control animals. VA at 50 and 100 mg/kg dose significantly (p < 0.001) improved the habituation memory, decreased the AChE, corticosterone, TNF-α, and increased the antioxidants (p < 0.001). VA (100 mg/kg) exhibited dose-dependent effect in all parameters with p < 0.001 except antioxidants in which VA showed the significance of p < 0.01. DISCUSSION AND CONCLUSION: VA exhibited reduction in AChE, TNF-α, and corticosterone with improved antioxidants to contribute neuroprotection and could be an effective therapeutic agent for treating neurodegenerative disorders.


Subject(s)
Cognition Disorders/prevention & control , Neurodegenerative Diseases/prevention & control , Neuroprotective Agents/administration & dosage , Streptozocin/toxicity , Vanillic Acid/administration & dosage , Animals , Antioxidants/administration & dosage , Cognition Disorders/chemically induced , Cognition Disorders/metabolism , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/metabolism , Infusions, Intraventricular , Male , Mice , Neurodegenerative Diseases/chemically induced , Neurodegenerative Diseases/metabolism , Oxidative Stress/drug effects , Streptozocin/administration & dosage
3.
Indian J Pharmacol ; 46(3): 298-302, 2014.
Article in English | MEDLINE | ID: mdl-24987177

ABSTRACT

OBJECTIVES: The present study was designed to evaluate the ameliorative effect of Elaeocarpus ganitrus on gentamicin (GM)-induced nephrotoxicity in rats. MATERIALS AND METHODS: E. ganitrus (100, 200, and 400 mg/kg body weight) was administered orally to male Wistar rats. GM (100 mg/kg) was used to induce nephrotoxicity. Study parameters include serum albumin, creatinine, blood urea nitrogen (BUN), uric acid, creatinine, and albuminuria. Total protein in serum, antioxidant enzymes activities, phagocytic index, and neutrophil adhesion assays were performed to determine oxidative stress and immunomodulatory action of E. ganitrus. RESULTS: The results revealed that coadministration of E. ganitrus significantly reduced the elevated level of serum creatinine, BUN, uric acid, and albuminuria with considerable increase in the serum albumin and urine creatinine. Furthermore, E. ganitrus noticeably increased serum total protein and antioxidant enzyme levels with significant alteration in phagocytic index and neutrophil adhesion assay when compared with GM-treated group in a dose-dependent manner. CONCLUSION: The present study revealed that ethanolic extract of E. ganitrus seeds has immunomodulatory and nephroprotective activity.


Subject(s)
Elaeocarpaceae , Kidney Diseases/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Protective Agents/therapeutic use , Animals , Blood Proteins/metabolism , Blood Urea Nitrogen , Catalase/metabolism , Cell Adhesion/drug effects , Creatinine/blood , Creatinine/urine , Gentamicins , Glutathione/metabolism , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Kidney Diseases/blood , Kidney Diseases/chemically induced , Kidney Diseases/pathology , Kidney Function Tests , Male , Neutrophils/drug effects , Neutrophils/physiology , Phagocytosis/drug effects , Plant Extracts/pharmacology , Protective Agents/pharmacology , Rats, Wistar , Seeds , Superoxide Dismutase/metabolism , Uric Acid/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...